Evidence map›Paper›PMID 36153501›Full record

ArticleBMC infectious diseases2022

Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial.

Win Htike, Win Han Oo, Thet Lynn, Lun Sovanda, Paul A Agius, May Chan Oo, Naw Hkawng Galau, Kaung Myat Thu, Aung Khine Zaw, Ei Phyu Htwe and 9 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05117567 (A Personal Protection Package for Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05117567 naunknown statusnot on this map

A Personal Protection Package for Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia: A Stepped-wedge Trial With Nested Mixed-methods Study

TypeinterventionalSponsorMacfarlane Burnet Institute for Medical Research and Public Health LtdRan2021 to 2022Enrolled5,868ConditionsPlasmodium InfectionArmsPersonal protection package
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Topical repellents for malaria prevention.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Forest-Going as a Risk Factor for Confirmed Malaria in Champasak Province, Lao PDR: A Case-Control Study.International journal of environmental research and public health · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 4 countries.

Win Htike *Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia. win.htike@burnet.edu.au.ORCID http://orcid.org/0000-0003-2820-477X
Win Han Oo *Disease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Thet LynnHealth Poverty Action, London, UK.
Lun SovandaHealth Poverty Action, London, UK.
Paul A AgiusDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
May Chan OoDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Naw Hkawng GalauDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Kaung Myat ThuDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Aung Khine ZawDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Ei Phyu HtweDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Julia C CuttsDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Ellen A KearneyDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Nick ScottDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Katherine O'FlahertyDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia.
Bangyuan WangHealth Poverty Action, London, UK.
Boualam KhamlomeCenter of Malariology Parasitology and Entomology, Ministry of Health, Vientiane, Lao PDR.
Phoutnalong VilayCenter of Malariology Parasitology and Entomology, Ministry of Health, Vientiane, Lao PDR.
Sovannaroth SivNational Center for Parasitology Entomology and Malaria Control, Ministry of Health, Phnom Penh, Cambodia.
Freya J I FowkesDisease Elimination Program, Burnet Institute, 85 Commercial Road, Melbourne, VIC, 3004, Australia. freya.fowkes@burnet.edu.au.
Burnet Institute · AUAction for ME · GBMinistry of Health · RWMinistry of Health · KH

Funding

Regional Artemisinin-resistance Initiative (RAI3E) grant QSE-M-UNOPS-BI-20864-007-60
6 · The paper itself

Abstract

backgroundCountries of the Greater Mekong Sub-region aim to achieve malaria elimination by 2030. In the region, malaria is concentrated in high-risk areas and populations such as forest-going mobile and migrant populations (MMPs). However, routine protective measures such as long-lasting insecticidal nets do not prevent all infectious bites in these high-risk populations. Evidence for the effectiveness of a personal protection package tailored to forest-going MMPs which is acceptable, feasible, and cost-effective for reducing malaria transmission is required to inform the malaria elimination toolkit in the region.

methodsA personal protection package consisting of long-lasting insecticidal hammock net, insect repellent and health communication pamphlet was developed in consultation with relevant implementing partners from Cambodia and Lao PDR. An open stepped-wedge cluster-randomised controlled trial will be conducted over a period of 12 months in a minimum of 488 villages (~ 428 in Lao PDR and ~ 60 in Cambodia) to evaluate the effectiveness of the personal protection package. Villages will be randomised into 11 blocks, with blocks transitioned in random order from control to intervention states at monthly intervals, following a 1-month baseline period. The primary outcome of the trial is the prevalence of Plasmodium spp. infection diagnosed by rapid diagnostic test. Difference in prevalence of malaria infection will be estimated across intervention and control periods using generalized linear mixed modelling. Nested within the stepped-wedge cluster-randomised controlled trial is a mixed-methods study to explore the acceptability of the personal protection package, feasibility of implementing a personal protection package as a vector control intervention, and knowledge, attitude and practice of MMPs regarding malaria prevention; and cost-analysis to determine the cost-effectiveness of implementing a personal protection package. DISCUSSION: This study, using a rigorous design and mixed-methods methodology, will evaluate whether a personal protection package can reduce residual malaria transmission among forest-going MMPs in Cambodia and Lao PDR. It will also measure implementation research outcomes such as effectiveness of the intervention package, cost-effectiveness, acceptability, and feasibility, in order to inform potential national and regional policy. Trial registration This trial was prospectively registered on ClinicalTrials.gov (NCT05117567) on 11th November 2021.

Indexed as

InsecticidesInsect RepellentsMalariaTransients and MigrantsCambodiaForestsHumansLaosRandomized Controlled Trials as TopicInsecticidesInsect RepellentsCommunity-delivered interventionEliminationFalciparumMalariaMigrantPreventionVectorVivax

Identifiers

PMID36153501
PMCPMC9509546
OpenAlexW4297184320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.